Trial to test Lymphoseek in patients with colorectal cancer

02/4/2013 | AuntMinnie.com (free registration)

Navidea Biopharmaceuticals has formed a partnership with Maimonides Medical Center in New York that will focus on an open-label clinical trial involving Lymphoseek, a radiopharmaceutical designed to stage cancers by pinpointing the lymph nodes that drain from a primary tumor. The trial will test the agent in patients with colorectal cancer and is set to start in the first half of the year.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX